SENTA News

Today, SENTA (“Southern Ear, Nose, Throat and Allergy Physicians”), proudly announces that Reston Ear, Nose and Throat (“Reston ENT”) is joining our premier network of ENT and Allergy providers. SENTA Partners is backed by Shore Capital Partners, and committed to partnering with leading physicians to build a premier network of ENT and allergy services in the U.S. With the addition of Reston ENT, SENTA welcomes a key partner in Virginia and expands its footprint into a new state and the National Capital region. This partnership compounds the tremendous growth SENTA has achieved over the past 12 months.

Today, SENTA (“Southern Ear, Nose, Throat and Allergy Physicians”), proudly announces that Allergy, Asthma & Immunology Associates of South Texas (“AllergySA”) is joining the physician led, patient focused alliance. With the addition of AllergySA, SENTA welcomes a key partner in Texas and expands its footprint into a new state and region. This partnership further solidifies SENTA’s substantial growth in early 2022.

SENTA proudly announces that South Carolina ENT, Allergy & Sleep Medicine (“SCENT”) is joining the physician-led, patient-focused alliance. This new geography with SCENT broadens SENTA’s reach and expertise in a key market by adding 21 providers who work across 10 locations.